Odom Lab: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
We are located in the new [http://science.cancerresearchuk.org/cri/ Cancer Research UK: Cambridge Research Institute]. Our research goal is to understand the systems-level transcriptional mechanisms underlying mammalian cell specification, which are often perturbed in carcinomas and diabetes, using | We are located in the new [http://science.cancerresearchuk.org/cri/ Cancer Research UK: Cambridge Research Institute]. Our research goal is to understand the systems-level <br> | ||
transcriptional mechanisms underlying mammalian cell specification, which are often perturbed in carcinomas and diabetes, <br> | |||
using pancreatic beta-cells and liver hepatocytes as models. | |||
{| cellspacing="3" | {| cellspacing="3" | ||
Line 16: | Line 18: | ||
<h3>Research</h3> | <h3>Research</h3> | ||
*[[Odom:Systems Biology|General]] | |||
*[[Odom:Mapping Regulatory Circuitry|Mapping Regulatory Circuitry]] | |||
*[[Odom:miRNA Functional Genomics|Functional Genomics]] | |||
*[[Odom:Conservation of Regulation|Conservation of Regulation]] | |||
<h3>[[Odom | <h3>[[Odom:Publications|Publications]]</h3> | ||
<h3>[[Odom:Protocols|Protocols]]</h3> | |||
<h3>Links</h3> | <h3>Links</h3> |
Revision as of 16:54, 16 August 2006
We are located in the new Cancer Research UK: Cambridge Research Institute. Our research goal is to understand the systems-level
transcriptional mechanisms underlying mammalian cell specification, which are often perturbed in carcinomas and diabetes,
using pancreatic beta-cells and liver hepatocytes as models.
|